Bringing natural killer cells to the clinic: ex vivo manipulation

Richard W Childs1, Maria Berg

  • 11Section of Transplantation Immunotherapy, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Insights

Natural killer (NK) cells are crucial for innate immunity against viruses and cancer. This review explores methods to activate and expand human NK cells for immunotherapy, highlighting differences in cell populations.

Area of Science:

  • Immunology
  • Cancer Research
  • Cell Therapy

Background:

  • Natural killer (NK) cells mediate innate immune responses against viral infections and tumors.
  • NK cells possess the ability to eliminate cancer cells without prior antigen recognition.
  • The full therapeutic potential of NK cell immunotherapy remains largely untapped.

Purpose of the Study:

  • To review novel methods for activating and expanding human NK cells ex vivo.
  • To discuss the application of these expanded NK cells in adoptive transfer therapies.
  • To highlight phenotypic and functional distinctions between different NK cell preparations.

Main Methods:

  • Review of existing literature on NK cell activation and expansion techniques.
  • Analysis of phenotypic markers and functional assays for NK cell characterization.
  • Comparison of freshly isolated, cytokine-activated, and ex vivo-expanded NK cell populations.

Main Results:

  • Novel ex vivo methods offer promising strategies for enhancing NK cell populations.
  • Significant phenotypic and functional variations exist among different NK cell preparations.
  • Ex vivo expansion can yield potent NK cell populations suitable for immunotherapy.

Conclusions:

  • Ex vivo activation and expansion are key to realizing the therapeutic potential of NK cells.
  • Understanding NK cell heterogeneity is crucial for optimizing adoptive cell therapy protocols.
  • Further research into NK cell manipulation will advance cancer and antiviral immunotherapy.

Related Concept Videos